It is conceivable that the differing ALS versus FTLD phenotypes reflect the impact of hypomethylated arginine residues or of missense mutation on different, cell-type specific cargo elements that that are misprocessed by the pathological, stable fibrillar FUS condensates, however these hypothesis require further investigation. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.